Search
Font size
click to adjust
Page tools
- Add to info basket
- Black-and-white version
- Text version
- Printer friendly version
- Bookmark this page
Your opinion counts
Financial Report
Podcast Center
News
01/07/09, Research & Development Visanne® - new long-term treatment for endometriosis submitted for registration in Europe Berlin, January 7, 2009 – Bayer Schering Pharma AG, Germany, has submitted Visanne® for the treatment of endometriosis for registration to all Member States of the European Community. The Neth... more
12/08/08, Rivaroxaban/Xarelto Xarelto® Reduces Symptomatic VTE and Death Following Knee or Hip Replacement Surgery by More Than 50% Compared to Enoxaparin in Pooled Analysis of RECORD Clinical Trial Program Pooled Analysis of RECORD1-4 Trials Confirms Significant Benefit in Clinical Outcomes for Patients Treated with Xarelto / RECORD4 Study Demonstrates Xarelto is the Only Oral Anticoagulant to Show Cli... more
12/04/08, Company Bayer expands men’s healthcare portfolio Licence agreement for innovative testosterone gel also covers emerging markets more
In Focus
Bayers Perspective on Innovation 2008
12th December 2008 - New technologies and products at the Perspective on Innovation 2008
At this year´s press conference on "Bayer´s Perspective on Innovation 2008", innovation champions of the Bayer group were in the focus. Werner Wenning (Chairman o...
more
In focus
At this year´s press conference on "Bayer´s Perspective on Innovation 2008", innovation champions of the Bayer group were in the focus. more
Press archive
Here you will find the
press archive
Contact
Here you will find your Bayer Schering Pharma press contacts. more